Necessity for surgical revision of defibrillator leads implanted long-term: Causes and management
DOI 10.1161/CIRCULATIONAHA.107.740670, PII 0000301720080527000005
Eckstein J, Koller MT, Zabel M, et al. (2008) Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation 117:2727-2733 (Pubitemid 351770453)
(2008)Circulation, vol.117, Issue.21, pp. 2727-2733
Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement
DOI 10.1016/j.eupc.2003.09.001, PII S1099512903001399
Lickfett L, Bitzen A, Arepally A, et al. (2004) Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 6:25-31 (Pubitemid 38949864)
Clinical experience with a novel subcutaneous implantable defibrillator system in a single center
DOI 10.1007/s00392-011-0303-6 [Epub ahead of print]
Dabiri Abkenari L, Theuns DA, Valk SD, et al. (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cadiol: DOI 10.1007/s00392-011-0303-6 [Epub ahead of print]
Evaluation of four distinct subcutaneous implantable defibrillator (S-ICD) lead systems in humans
Grace AA, Hood M, Smith WM, et al. (2006) Evaluation of four distinct subcutaneous implantable defibrillator (S-ICD) lead systems in humans. Heart Rhythm 4(5):132
A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker
Van Opstal J, Geskes G, Debie L (2011) A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker. Europace 13:141-142
Use of a primary prevention totally subcutaneous defibrillator in hypertrophic cardiomyopathy
Baez-Escudero JL, Beshai JF, Burke MC (2010) Use of a primary prevention totally subcutaneous defibrillator in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 3:560-561
Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
Mirowski M, Reid PR, Mower MM, et al. (1980) Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings. N Engl J Med 7:322-324 (Pubitemid 10040022)